Red Hot Rare Diseases and Europe’s record funding with Regina Hodits, Angelini Ventures | E63
Regina Hodits, who I have known for many years, spent 15 years at Wellington Partners...
Top 10 Biotech Exits in Europe Since 2023
Europe’s biotech M&A market has been on a tear. Since 2023, acquirers from MSD to...
Top 50 Investors in Biotech in 2026: Europe’s Most Active Life Sciences Funds
Who is writing the cheques that fund Europe’s next generation of medicines? Based on fund...
Christoph Lengauer, Curie.Bio | Biotech Founders, Venture Capital | E57
We admire the mountains of Austria with the co-founder of Curie.Bio, a founder-friendly fund that...
How Europe could have more Biotech Champions like Argenx
For decades, the narrative of European biotech has been one of “innovation flight”: brilliant science...
Sander Slootweg, Forbion 🇳🇱 | European Biotech Investment, Venture Capital | E56
Forbion celebrates its 20th anniversary this year, with a whopping €5 billion raised so far....
Baker Brothers’ Biotech Investing Secrets
In a biotech landscape dominated by hype and volatility, the Baker Brothers have emerged as...
